Neurocrine Biosciences Inc (NBIX)

03:30 AM

Can Neurocrine Biosciences Inc. stock weather global recessionMarket Rally & Real-Time Volume Analysis Alerts - newser.com

03:30 AM

03:01 AM

Neurocrine Biosciences to Present at Upcoming Investor Conferences - Your Wyoming Link

03:01 AM

12:16 PM

Assessing Neurocrine Biosciences After Stock Rises 7.8% and Partnership Expansion News - Yahoo Finance

12:16 PM

11:47 AM

What analysts say about Neurocrine Biosciences Inc NB3 stockSector Performance Review & Free Turn Volatility To Profit - earlytimes.in

11:47 AM

06:42 AM

Neurocrine’s depression candidate fails mid-stage study but analysis continues - The Pharma Letter

06:42 AM

06:34 AM

Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherWeekly Gains Report & Daily Profit Focused Screening - newser.com

06:34 AM

05:28 AM

Neurocrine Biosciences (NBIX): Assessing Valuation After Lead Depression Drug Misses Phase 2 Study Goal - simplywall.st

05:28 AM

05:18 AM

Is it time to cut losses on Neurocrine Biosciences Inc.Portfolio Update Report & Real-Time Chart Pattern Alerts - newser.com

05:18 AM

03:07 AM

What makes Neurocrine Biosciences Inc. (NB3) stock appealing to growth investorsGlobal Markets & Entry Point Confirmation Signals - newser.com

03:07 AM

02:09 AM

What valuation multiples suggest for Neurocrine Biosciences Inc. stockPortfolio Value Summary & Daily Volume Surge Signals - newser.com

02:09 AM

01:39 AM

Neurocrine Biosciences fails mid-stage study of depression drug - MSN

01:39 AM

12:53 PM

Why Neurocrine Biosciences Inc. stock remains resilientProduct Launch & High Return Trade Opportunity Guides - newser.com

12:53 PM

Nov 11, 2025

Neurocrine Bio Drug Licensed From Takeda Flunks Mid-Stage Test in Depression - MedCity News

Nov 11, 2025

Nov 11, 2025

Neurocrine (Nasdaq: NBIX) to join Jefferies Nov. 18, Piper Sandler Dec. 2 webcasts - Stock Titan

Nov 11, 2025

Nov 11, 2025

Looking for a Growth Stock? 3 Reasons Why Neurocrine (NBIX) is a Solid Choice - sharewise.com

Nov 11, 2025

Nov 11, 2025

How Neurocrine Biosciences Inc. stock responds to policy changesWeekly Trend Recap & Verified Short-Term Trading Plans - newser.com

Nov 11, 2025

Nov 11, 2025

Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile - Benzinga

Nov 11, 2025

Nov 11, 2025

Neurocrine’s Depression Drug Misses In Phase II - Citeline News & Insights

Nov 11, 2025

Nov 11, 2025

Morgan Stanley Lowers Price Target for Neurocrine Biosciences (N - GuruFocus

Nov 11, 2025

Nov 11, 2025

Neurocrine’s depression drug fails to meet primary endpoint in phase 2 - Investing.com Nigeria

Nov 11, 2025

Nov 10, 2025

Neurocrine’s depression drug fails to meet primary endpoint in phase 2 By Investing.com - Investing.com South Africa

Nov 10, 2025

Nov 10, 2025

Neurocrine chalks up a depression drug failure - BioPharma Dive

Nov 10, 2025

Nov 10, 2025

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder - PR Newswire

Nov 10, 2025

Nov 10, 2025

symbol__ Stock Quote Price and Forecast - CNN

Nov 10, 2025

Nov 10, 2025

Is Neurocrine Biosciences Inc. stock trading near support levelsStop Loss & Growth Focused Stock Pick Reports - newser.com

Nov 10, 2025

Nov 10, 2025

Can Neurocrine Biosciences Inc. (NB3) stock beat analyst consensusDividend Hike & Precise Entry and Exit Recommendations - newser.com

Nov 10, 2025

Nov 10, 2025

What moving averages say about Neurocrine Biosciences Inc.2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com

Nov 10, 2025

Nov 10, 2025

How to build a dashboard for Neurocrine Biosciences Inc. stockIPO Watch & Short-Term Swing Trade Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

What earnings revisions data tells us about Neurocrine Biosciences Inc.Risk Management & Free Community Consensus Stock Picks - newser.com

Nov 10, 2025

Nov 09, 2025

Will Neurocrine Biosciences Inc. (NB3) stock split increase liquidity2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com

Nov 09, 2025

Nov 09, 2025

Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com

Nov 09, 2025

Nov 09, 2025

What data driven models say about Neurocrine Biosciences Inc.’s future2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 09, 2025

Nov 09, 2025

What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Action & Precise Swing Trade Entry Alerts - newser.com

Nov 09, 2025

Nov 07, 2025

Is Neurocrine Biosciences Inc. (NB3) stock a buy during volatile marketsJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com

Nov 07, 2025

Nov 07, 2025

Neurocrine Biosciences (NBIX) Is Up 12.1% After Strong Q3 Earnings Report and Upgraded Guidance – Has The Bull Case Changed? - Sahm

Nov 07, 2025

Nov 07, 2025

Measuring Neurocrine Biosciences Inc.’s beta against major indicesWeekly Trade Report & AI Forecasted Entry and Exit Points - newser.com

Nov 07, 2025

Nov 07, 2025

Applying sector rotation models to Neurocrine Biosciences Inc.Market Sentiment Review & Safe Capital Preservation Plans - newser.com

Nov 07, 2025

Nov 06, 2025

Neurocrine Biosciences : Statement of Changes in Beneficial Ownership (Form 4) - MarketScreener

Nov 06, 2025

Nov 06, 2025

Neurocrine Biosciences Director Sells 18,000 Shares - TradingView

Nov 06, 2025

Nov 06, 2025

[Form 4] NEUROCRINE BIOSCIENCES INC Insider Trading Activity - Stock Titan

Nov 06, 2025

Nov 06, 2025

Earnings Estimates Rising for Neurocrine (NBIX): Will It Gain? - sharewise.com

Nov 06, 2025